GLP-1 medications like Ozempic and Wegovy are in high demand but cannot solve the obesity crisis alone, according to payer executives. Obesity is a chronic and complex condition that requires a multidisciplinary approach for effective management. However, obesity management is often fragmented, and primary care physicians lack the incentive and training to address it effectively. To improve obesity management, payers, providers, tech companies, and healthcare stakeholders should collaborate and fuse their data to create a personalized view of each member’s obesity story. This personalized approach can help determine the most effective treatment options, including GLP-1 medications, weight loss medication, surgery, remote monitoring, and nutrition coaching. In addition, community and population health issues should be considered in addressing the nation’s obesity crisis.
Source link
How Are Payers Approaching Obesity Management?
